Med. , 172 , 1217 C 1224 ( 1990. killermAbmonoclonal antibodyMLTCmixed lymphocyte tumor cell tradition Referrals 1. ) Russell , S. J.Lymphokine gene therapy for malignancy . Immunol. Today , 11 , 196 C 200 ( 1990. ). [PubMed] [Google Scholar] 2. ) Watanabe , Y. and Sakata , T.Highly efficient action of autocrine mouse interferon\ expressed via a retroviral vector . Eur. J. Immunol. , 18 , 1627 C 1630 ( 1988. ). [PubMed] [Google Scholar] 3. ) Watanabe , Cidofovir (Vistide) Y. , Kuribayashi , K. , Miyatake , S. , Nishihara , K. , Nakayama , E. , Taniyama , T. and Sakata , T.Exogenous expression of mouse interferon\ cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti\tumor immunity . Proc. Natl. Acad. Sci. USA , 86 , 9456 C 9460 ( 1989. ). [PMC free article] [PubMed] [Google Scholar] 4. ) Maruguchi , Y. , Toda , K. , Fujii , K. , Imamura , S. and Watanabe , Y.Survival period of tumor\bearing mice is definitely prolonged after the interferon\\producing gene transfer . Malignancy Lett. , 60 , 41 C 49 ( 1991. ). [PubMed] Rabbit polyclonal to PLRG1 [Google Scholar] 5. ) Gansbacher , B. , Bannerji , R. , Daniels , B. , Zier , K. , Cronin , K. and Gilboa , E.Retroviral vector\mediated \interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity . Tumor Res. , 50 , 7820 C 7825 ( 1990. ). [PubMed] [Google Scholar] 6. ) Esumi , N. , Hunt , B. , Itaya , Cidofovir (Vistide) T. and Frost , P.Reduced tumorigenicity of murine tumor cells secreting \interferon is due to nonspecific host responses and is unrelated to class I major histocompatibility complex expression . Malignancy Res. , 51 , 1185 C 1189 ( 1991. ). [PubMed] [Google Scholar] 7. ) Fearon , E. R. , Pardoll , D. M. , Itaya , T. , Golumbek , P. , Levitsky , H. I. , Simons , J. W. , Karasuyama , H. , Vogelstein , B. and Frost , P.Interleukin\2 production by tumor cells bypasses T helper function in the generation of an antitumor response . Cell , 60 , 397 C 403 ( 1990. ). [PubMed] [Google Scholar] 8. ) Gansbacher , B. , Zier , K. , Daniels , B. , Cronin , K. , Bannerji , R. and Gilboa , E.Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity . J. Exp. Med. , 172 , 1217 C 1224 ( 1990. ). [PMC free article] [PubMed] [Google Scholar] 9. ) Tepper , R. I. , Pattengale , P. K. and Leder , P.Murine interleukin\4 displays potent anti\tumor activity in vivo . Cell , 57 , 503 C 512 ( 1989. ). [PubMed] [Google Scholar] 10. ) Golumbek , P. T. , Lazenby , A. J. , Levintsky , H. I. , Cidofovir (Vistide) Jaffee , L. M. , Karasuyama , H. , Baker , M. and Pardoll , D. M.Treatment of established renal malignancy by tumor cells engineered to secrete interleukin\4 . Technology , 254 , 713 C 716 ( 1991. ). [PubMed] [Google Scholar] 11. ) Hock , H. , Dorsch , M. , Diamanstein , T. and Blankenstein , T.Interleukin 7 induces CD4+ T cell\dependent tumor rejection . J. Exp. Med. , 174 , 1291 C 1298 ( 1991. ). [PMC free article] [PubMed] [Google Scholar] 12. ) Blankenstein , T. , Qin , Cidofovir (Vistide) Z. , berla , K. , Mller , W. , Rosen , H. , Volk , H. \D. and Diamanstein , T.Tumor suppression after tumor cell\targeted tumor necrosis element gene transfer . J. Exp. Med. , 173 , 1047 C 1052 ( 1991. ). [PMC free article] [PubMed] [Google Scholar] 13. ) Teng , M. N. , Park , B. H. , Koeppen , H. K. W , Tracey , K. J. , Fendly , B. M. and Schreiber , H.Long\term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T\cell immunity . Proc. Natl. Acad. Sci. USA , 88 , 3535 C 3539 ( 1991. ). [PMC free article] [PubMed] [Google Scholar] 14. ).